Chromosomal aberrations in UVB-induced tumors of immunosuppressed mice

Genes Chromosomes and Cancer

Volumn 48, Issue 6, 2009, Pages 490-501

  Dworkin, Amy M ^a,b   Tober, Kathleen L ^a,b   Duncan, F Jason ^a,b   Yu, Lianbo ^a,b   VanBuskirk, Anne M ^b,c   Oberyszyn, Tatiana M ^a,b   Toland, Amanda Ewart ^b,d,e  

^a OHIO STATE UNIVERSITY   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c TAKEDA PHARMACEUTICALS   (United States)

^d THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^e NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RAPAMYCIN; TACROLIMUS; IMMUNOSUPPRESSIVE AGENT; TUMOR PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; CHROMOSOME ABERRATION; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; DRUG EFFECT; FEMALE; GENE IDENTIFICATION; GRAFT RECIPIENT; GRAFT REJECTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; ULTRAVIOLET B RADIATION; ANALYSIS OF VARIANCE; ANIMAL; CHEMICALLY INDUCED DISORDER; DISEASE MODEL; DNA MICROARRAY; GENE DOSAGE; GENETICS; HAIRLESS MOUSE; HUMAN; IMMUNE DEFICIENCY; METABOLISM; RADIATION INJURY; SKIN TUMOR; ULTRAVIOLET RADIATION;

ANIMALIA; MUS;

ANALYSIS OF VARIANCE; ANIMALS; CARCINOMA, SQUAMOUS CELL; CHROMOSOME ABERRATIONS; COMPARATIVE GENOMIC HYBRIDIZATION; DISEASE MODELS, ANIMAL; FEMALE; GENE DOSAGE; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOSUPPRESSIVE AGENTS; MICE; MICE, HAIRLESS; NEOPLASM PROTEINS; NEOPLASMS, RADIATION-INDUCED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; SKIN NEOPLASMS; ULTRAVIOLET RAYS;

EID: 65349147613     PISSN: 10452257     EISSN: 10982264     Source Type: Journal    
DOI: 10.1002/gcc.20657     Document Type: Article

References (38)

1. Al-Daraji WI, Grant KR, Ryan K, Saxton A, Reynolds NJ. 2002. Localization of calcineurin/NFAT in human skin and psoriasis and inhibition of calcineurin/NFAT activation in human keratinocytes by cyclosporin A. J Investig Dermatol 118:779-788. (Pubitemid 34526539)
2. Ashton KJ, Weinstein SR, Maguire DJ, Griffiths LR. 2003. Chromosomal aberrations in squamous cell carcinoma and solar keratoses revealed by comparative genomic hybridization. Arch Dermatol 139:876-882. (Pubitemid 36898922)
3. Augustine JJ, Bodziak KA, Hricik DE. 2007. Use of sirolimus in solid organ transplantation. Drugs 67:369-391.
4. Benjamin CL, Melnikova VO, Ananthaswamy HN. 2008. P53 protein and pathogenesis of melanoma and nonmelanoma skin cancer. Adv Exp Med Biol 624:265-282.
5. Berg D, Otley CC. 2002. Skin cancer in organ transplant recipients: Epidemiology, pathogenesis, and management. J Am Acad Dermatol 47:1-17; Quiz 18-20.
6. Blaha P, Bigenzahn S, Koporc Z, Schmid M, Langer F, Selzer E, Bergmeister H, Wrba F, Kurtz J, Kiss C, Roth E, Muehlbacher F, Sykes M, Wekerle T. 2003. The influence of immunosuppressive drugs on tolerance induction through bone marrow transplantation with costimulation blockade. Blood 101:2886-2893. (Pubitemid 36857658)
7. Boukamp P. 2005. Non-melanoma skin cancer: What drives tumor development and progression? Carcinogenesis 26:1657-1667.
8. Cao C, Lu S, Kivlin R, Wallin B, Card E, Bagdasarian A, Tamakloe T, Chu WM, Guan KL, Wan Y. 2008. AMP-activated protein kinase contributes to UV- and H2O2-induced apoptosis in human skin keratinocytes. J Biol Chem 283:28897-28908.
9. Duncan FJ, Wulff BC, Tober KL, Ferketich AK, Martin J, Thomas-Ahner JM, Allen SD, Kusewitt DF, Oberyszyn TM, Vanbuskirk AM. 2007. Clinically relevant immunosuppressants influence UVB-induced tumor size through effects on inflammation and angiogenesis. Am J Transplant 7:2693-2703. (Pubitemid 350045778)
10. Euvrard S, Kanitakis J, Decullier E, Butnaru AC, Lefrancois N, Boissonnat P, Sebbag L, Garnier JL, Pouteil-Noble C, Cahen R, Morelon E, Touraine JL, Claudy A, Chapuis F. 2006. Subsequent skin cancers in kidney and heart transplant recipients after the first squamous cell carcinoma. Transplantation 81:1093-1100. (Pubitemid 43754657)
11. Faurschou A, Gniadecki R. 2008a. TNF-alpha stimulates Akt by a distinct aPKC-dependent pathway in premalignant keratinocytes. Exp Dermatol 17:992-997.
12. Faurschou A, Gniadecki R, Calay D, Wulf HC. 2008b. TNF-alpha impairs the S-G2/M cell cycle checkpoint and cyclobutane pyrimidine dimer repair in premalignant skin cells: Role of the PI3K-Akt pathway. J Investig Dermatol 128:2069-2077. (Pubitemid 352001204)
13. Gordon A, Glazko G, Qiu X, Yakovley A. 2007. Control of the mean number of false discoveries, Bonferroni, and stability of multiple testing. Ann Appl Stat 1:179-190.
14. Gutierrez-Dalmau A, Campistol JM. 2007. Immunosuppressive therapy and malignancy in organ transplant recipients: A systematic review. Drugs 67:1167-1198. (Pubitemid 46871026)
15. Hengge UR. 2008. Role of viruses in the development of squamous cell cancer and melanoma. Adv Exp Med Biol 624:179-186.
16. Iwasaki K. 2007. Metabolism of tacrolimus (FK506) and recent topics in clinical pharmacokinetics. Drug Metab Pharmacokinet 22:328-335.
17. Jin Y, Martins C, Jin C, Salemark L, Jonsson N, Persson B, Roque L, Fonseca I, Wennerberg J. 1999. Nonrandom karyotypic features in squamous cell carcinomas of the skin. Genes Chromosomes Cancer 26:295-303. (Pubitemid 29529574)
18. Lee JY, Kang WH. 2003. Effect of cyclosporin A on melanogenesis in cultured human melanocytes. Pigment Cell Res 16:504-508. (Pubitemid 37093028)
19. Mitsuyasu RT. 2008. Non-AIDS-defining malignancies in HIV. Top HIV Med 16:117-121.
20. Nishio H, Matsui K, Tsuji H, Tamura A, Suzuki K. 2000. Immunolocalization of calcineurin and FKBP12, the FK506-binding protein, in Hassall's corpuscles of human thymus and epidermis. Histochem Cell Biol 114:9-14. (Pubitemid 30609851)
21. Popp S, Waltering S, Holtgreve-Grez H, Jauch A, Proby C, Leigh IM, Boukamp P. 2000. Genetic characterization of a human skin carcinoma progression model: From primary tumor to metastasis. J Investig Dermatol 115:1095-1103. (Pubitemid 32037456)
22. Purdie KJ, Lambert SR, Teh MT, Chaplin T, Molloy G, Raghavan M, Kelsell DP, Leigh IM, Harwood CA, Proby CM, Young BD. 2007. Allelic imbalances and microdeletions affecting the PTPRD gene in cutaneous squamous cell carcinomas detected using single nucleotide polymorphism microarray analysis. Genes Chromosomes Cancer 46:661-669. (Pubitemid 46802333)
23. Santini MP, Talora C, Seki T, Bolgan L, Dotto GP. 2001. Cross talk among calcineurin, Sp1/Sp3, and NFAT in control of p21(WAF1/CIP1) expression in keratinocyte differentiation. Proc Natl Acad Sci USA 98:9575-9580. (Pubitemid 32769345)
24. Saul AN, Oberyszyn TM, Daugherty C, Kusewitt D, Jones S, Jewell S, Malarkey WB, Lehman A, Lemeshow S, Dhabhar FS. 2005. Chronic stress and susceptibility to skin cancer. J Natl Cancer Inst 97:1760-1767. (Pubitemid 41782285)
25. Smit NP, Van Rossum HH, Romijn FP, Sellar KJ, Breetveld M, Gibbs S, Van Pelt J. 2008. Calcineurin activity and inhibition in skin and (epi)dermal cell cultures. J Investig Dermatol 128: 1686-1690. (Pubitemid 351847373)
26. Smyth GK. 2004. Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 3:Article3. (Pubitemid 40664554)
27. Staatz CE, Tett SE. 2004. Clinical pharmacokinetics and pharmacodynamics of tacrolimus in solid organ transplantation. Clin Pharmacokinet 43:623-653. (Pubitemid 38981845)
28. Struijk L, van der Meijden E, Kazem S, ter Schegget J, de Gruijl FR, Steenbergen RD, Feltkamp MC. 2008. Specific betapapillomaviruses associated with squamous cell carcinoma of the skin inhibit UVB-induced apoptosis of primary human keratinocytes. J Gen Virol 89:2303-2314.
29. Thomas-Ahner JM, Wulff BC, Tober KL, Kusewitt DF, Riggenbach JA, Oberyszyn TM. 2007. Gender differences in UVBinduced skin carcinogenesis, inflammation, and DNA damage. Cancer Res 67;3468-3474. (Pubitemid 46724888)
30. Tober KL, Thomas-Ahner JM, Kusewitt DF, Oberyszyn TM. 2007. Effects of UVB on E prostanoid receptor expression in murine skin. J Investig Dermatol 127:214-221. (Pubitemid 46005681)
31. Veltman JA, Fridlyand J, Pejavar S, Olshen AB, Korkola JE, DeVries S, Carroll P, Kuo WL, Pinkel D, Albertson D, Cordon-Cardo C, Jain AN, Waldman FM. 2003. Array-based comparative genomic hybridization for genome-wide screening of DNA copy number in bladder tumors. Cancer Res 63:2872-2880. (Pubitemid 36667159)
32. Veness MJ, Quinn DI, Ong CS, Keogh AM, Macdonald PS, Cooper SG, Morgan GW. 1999. Aggressive cutaneous malignancies following cardiothoracic transplantation: The Australian experience. Cancer 85:1758-1764. (Pubitemid 29169677)
33. Verkler TL, Delongchamp RR, Miller BJ, Webb PJ, Howard PC, Parsons BL. 2008. Simulated solar light-induced p53 mutagenesis in SKH-1 mouse skin: A dose-response assessment. Mol Carcinog 47:599-607.
34. Weischer M, Rocken M, Berneburg M. 2007. Calcineurin inhibitors and rapamycin: Cancer protection or promotion? Exp Dermatol 16:385-393.
35. Wulff BC, Kusewitt DF, VanBuskirk AM, Thomas-Ahner JM, Duncan FJ, Oberyszyn TM. 2008. Sirolimus reduces the incidence and progression of UVB-induced skin cancer in SKH mice even with coadministration of cyclosporine A. J Investig Dermatol 128:2467-2473.
36. Yarosh DB, Boumakis S, Brown AB, Canning MT, Galvin JW, Both DM, Kraus E, O'Connor A, Brown DA. 2002. Measurement of UVB-Induced DNA damage and its consequences in models of immunosuppression. Methods 28:55-62.
37. Yarosh DB, Pena AV, Nay SL, Canning MT, Brown DA. 2005. Calcineurin inhibitors decrease DNA repair and apoptosis in human keratinocytes following ultraviolet B irradiation. J Investig Dermatol 125:1020-1025.
38. Zwerner J, Fiorentino D. 2007. Mycophenolate mofetil. Dermatol Ther 20:229-238. (Pubitemid 350029312)